AlzeCure Pharma AB - ESG Rating & Company Profile powered by AI
This webpage of AlzeCure Pharma AB is assembled by All Street Sevva using leading artificial intelligence. Browse to the bottom of this page for potential risks for AlzeCure Pharma AB based on industry, location and size. This dashboard includes a Q&A table for AlzeCure Pharma AB.
AlzeCure Pharma AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 4.0, social score of 8.0 and governance score of 2.7.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 744 | Sopharma AD | 5.0 | High |
| 744 | vTv Therapeutics Inc | 5.0 | High |
| 764 | AlzeCure Pharma AB | 4.9 | High |
| 764 | BetterLife Pharma Inc | 4.9 | High |
| 764 | Acerus Pharmaceuticals Corporation | 4.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does AlzeCure Pharma AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose current and historical energy intensity?
Sign up for free to unlockDoes AlzeCure Pharma AB report the average age of the workforce?
Sign up for free to unlockDoes AlzeCure Pharma AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose cybersecurity risks?
Sign up for free to unlockDoes AlzeCure Pharma AB offer flexible work?
Sign up for free to unlockDoes AlzeCure Pharma AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes AlzeCure Pharma AB conduct supply chain audits?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes AlzeCure Pharma AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose water use targets?
Sign up for free to unlockDoes AlzeCure Pharma AB have careers partnerships with academic institutions?
Sign up for free to unlockDid AlzeCure Pharma AB have a product recall in the last two years?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose incidents of discrimination?
Sign up for free to unlockDoes AlzeCure Pharma AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas AlzeCure Pharma AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose parental leave metrics?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes AlzeCure Pharma AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes AlzeCure Pharma AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs AlzeCure Pharma AB involved in embryonic stem cell research?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose its waste policy?
Sign up for free to unlockDoes AlzeCure Pharma AB report according to TCFD requirements?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose energy use targets?
Sign up for free to unlockDoes AlzeCure Pharma AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes AlzeCure Pharma AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for AlzeCure Pharma AB
These potential risks are based on the size, segment and geographies of the company.
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I clinical trial for sleep disorders, traumatic brain injuries, and Alzheimer's disease; ACD857, ACD679, and ACD680 for Alzheimer's disease; ACD440, a VR1 antagonist that is in phase I clinical trial for neuropathic pain; and TrkA-NAM for osteoarthritic pain. The company was founded in 2012 and is based in Huddinge, Sweden.